DBr-1
DBr-1 is a potent BRD9 PROTAC degrader (KD: 13 nM). DBr-1 can overcome intrinsic resistance to VHL-degrader. Blue: DCAF1 binder , Black: linker, Pink: BRD9/BRD7 bromodomains inhibitor (HY-100352).
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dbr-1.html
Purity
98.87
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=C(C(C2=C3C=NC=C2)=CN(C)C3=O)C=C(OC)C(CN4CCC(OCCCCCC(N5CCN(C6=CC=C7C(N=C(C8(C9=CC=C(Cl)C=C9)CCCCC8)N=C7NCCN)=C6)CC5)=O)CC4)=C1
Molecular Formula
C55H68ClN9O5
Molecular Weight
970.64
References & Citations
[1]Schröder M, et al. DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. Nat Commun. 2024 Jan 4;15 (1) :275.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4047803 1.0 µg DNA
Iqcj sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
HCA030U078X150ACA 1 Piece/Case:1 Piece/ PACKS:1 PACKS/CASE
X30303μm7.8x150mm
Sign In for Pricing
View Details